Conor McNamara
Stock Analyst at RBC Capital
(0)
# 4906
Out of 5,345 analysts
111
Total ratings
11.11%
Success rate
-26.26%
Average return
Main Sectors:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
TECH Bio-Techne | Maintains: Sector Perform | 72 63 | 47.82 | 31.74% | 9 | May 8, 2025 | |
HOLX Hologic | Maintains: Sector Perform | 75 70 | 64.62 | 8.33% | 10 | May 2, 2025 | |
BIO Bio-Rad Laboratories | Maintains: Outperform | 409 392 | 229.42 | 70.87% | 11 | May 2, 2025 | |
RGEN Repligen | Maintains: Outperform | 202 189 | 121.12 | 56.04% | 11 | Apr 30, 2025 | |
AVTR Avantor | Maintains: Outperform | 24 20 | 13.04 | 53.37% | 7 | Apr 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 651 637 | 402.23 | 58.37% | 14 | Apr 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 250 250 | 190.09 | 31.52% | 9 | Apr 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 128 112 | 84.33 | 32.81% | 15 | Apr 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 7 4 | 1.32 | 203.03% | 3 | Mar 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 251 | 158.83 | 58.03% | 1 | Mar 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 64 61 | 31.86 | 91.46% | 11 | Feb 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 17 13 | 2.21 | 488.24% | 6 | Nov 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 8 7 | 3.01 | 132.56% | 4 | Aug 7, 2024 |